Department of Surgery, Ophthalmology Unit, Lagos State University College of Medicine, Lagos State, Nigeria.
Lagos State University Teaching Hospital, Lagos State, Nigeria.
Rom J Ophthalmol. 2024 Apr-Jun;68(2):99-107. doi: 10.22336/rjo.2024.20.
This study aimed to determine the ocular toxicity of the psychotropic drugs used by patients and to proffer suggestions on how to prevent visual impairment or blindness in patients on antipsychotics. This was a prospective, hospital-based cross-sectional study. Participants were adult patients between 18 and 70 years, diagnosed with psychosis, and who had been on antipsychotic medications for at least one year. All the recruited participants had an examination of the anterior and posterior segments of the eyes done. Schirmer's test, Tear film Break-up time (TBUT), Central Corneal thickness (CCT), Colour vision test, and Contrast sensitivity test were done. The collected data was analyzed using IBM SPSS 28.0. The study enrolled patients who were mainly females (55.1%). The highest age group of the cases was 29-38 years (29.7%). The examination of the eyes and investigations revealed that 10.2% of the respondents on antipsychotics had color vision deficiency and 25.4% - loss of contrast sensitivity. Lid pigmentation was observed in 20.3% and cataract in 32.2%. Degeneration of the peripheral retina was observed in 4.2% of patients on antipsychotic medication. Schirmer's test showed mild, moderate, and severe dry eyes in 11%,17.8%, and 20.3% of the participants respectively. The test for Central Corneal Thickness (CCT) showed 50.0% of the respondents had a thin cornea and 24.6% had a thick cornea. 17.8% of the surveyed respondents manifested high eye pressure. Discussion: Psychotropics are the gold standard for the treatment of psychotic episodes and disorders. The choice of drug, dosing, and mode of administration depends on the severity of the psychotic disorder. Higher doses of psychotropics were reported to cause toxicity in different organs in the body including the eyes, especially on long-term use and high dosage and this can affect the quality of life of the individual negatively. The earliest and most prominent side effect seen in patients on psychotic medication was dry eyes. There were a few cases of blinding eye diseases like glaucoma, and cataract. For these reasons, ophthalmic assessments should be included as part of the management of psychiatric patients early at the start of antipsychotic treatment. FGA = First Generation Antipsychotics, SGA = Second Generation Antipsychotics, TCAs = Tricyclic Antidepressants, CCT = Central Corneal Thickness, IOP = Intraocular Pressure, TBUT =Tear film Break-up Time, BIO = Binocular Indirect Ophthalmoscope.
本研究旨在确定患者使用的精神药物的眼毒性,并就如何预防抗精神病药物患者的视力损害或失明提出建议。这是一项前瞻性、基于医院的横断面研究。参与者为年龄在 18 至 70 岁之间、被诊断患有精神病且至少服用抗精神病药物一年的成年患者。所有招募的参与者都接受了眼部前段和后段的检查。施氏泪液测试、泪膜破裂时间(TBUT)、中央角膜厚度(CCT)、色觉测试和对比敏感度测试。使用 IBM SPSS 28.0 分析收集的数据。该研究纳入的患者主要为女性(55.1%)。病例中年龄最大的是 29-38 岁(29.7%)。眼部检查和调查显示,10.2%的抗精神病药物使用者有色觉缺陷,25.4%的抗精神病药物使用者对比敏感度下降。20.3%的人出现眼睑色素沉着,32.2%的人出现白内障。4.2%的抗精神病药物使用者出现周边视网膜变性。施氏泪液测试显示,11%、17.8%和 20.3%的参与者分别有轻度、中度和重度干眼症。中央角膜厚度(CCT)测试显示,50.0%的参与者角膜较薄,24.6%的参与者角膜较厚。17.8%的受访者眼压升高。讨论:精神药物是治疗精神病发作和障碍的金标准。药物的选择、剂量和给药方式取决于精神病障碍的严重程度。据报道,较高剂量的精神药物会在体内不同器官(包括眼睛)引起毒性,尤其是在长期使用和高剂量使用时,这会对个体的生活质量产生负面影响。在服用精神病药物的患者中,最早和最突出的副作用是干眼症。有少数病例出现青光眼和白内障等致盲眼病。出于这些原因,眼科评估应作为精神病患者管理的一部分,尽早在开始抗精神病治疗时进行。FGA = 第一代抗精神病药,SGA = 第二代抗精神病药,TCAs = 三环类抗抑郁药,CCT = 中央角膜厚度,IOP = 眼内压,TBUT = 泪膜破裂时间,BIO = 双目间接检眼镜。